LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease

Published:2012-01-25 Issue:1 Volume:7 Page:e30668
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bieghs Veerle,Van Gorp Patrick J.,Wouters Kristiaan,Hendrikx Tim,Gijbels Marion J.,van Bilsen Marc,Bakker Jaap,Binder Christoph J.,Lütjohann Dieter,Staels Bart,Hofker Marten H.,Shiri-Sverdlov Ronit

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.;J Ludwig;Mayo Clin Proc,1980

2. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.;LA Adams;J Hepatol,2005

3. Long term prognosis of fatty liver: risk of chronic liver disease and death.;S Dam-Larsen;Gut,2004

4. Long-term follow-up of patients with NAFLD and elevated liver enzymes.;M Ekstedt;Hepatology,2006

5. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.;AE Feldstein;Gut,2009

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medaka liver developed Human NAFLD-NASH transcriptional signatures in response to ancestral bisphenol A exposure;2024-07-16

2. 3D culture models to study pathophysiology of steatotic liver disease;Atherosclerosis;2024-06

3. Sex-specific expression of the human NAFLD-NASH transcriptional signatures in the liver of medaka with a history of ancestral bisphenol A exposure;2024-05-21

4. T cells with increased responsiveness cause obesity in mice without diet intervention;iScience;2024-04

5. Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis;Vascular Pharmacology;2024-03